Jason Drew Smith - Net Worth and Insider Trading
Jason Drew Smith Net Worth
The estimated net worth of Jason Drew Smith is at least $319,361 dollars as of 2024-11-29. Jason Drew Smith is the General Counsel of UroGen Pharma Ltd and owns about 25,226 shares of UroGen Pharma Ltd (URGN) stock worth over $319,361. Details can be seen in Jason Drew Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason Drew Smith has not made any transactions after 2024-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jason Drew Smith
Jason Drew Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason Drew Smith owns 1 companies in total, including UroGen Pharma Ltd (URGN) .
Click here to see the complete history of Jason Drew Smith’s form 4 insider trades.
Insider Ownership Summary of Jason Drew Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2024-09-09 | General Counsel |
Jason Drew Smith Latest Holdings Summary
Jason Drew Smith currently owns a total of 1 stock. Jason Drew Smith owns 25,226 shares of UroGen Pharma Ltd (URGN) as of September 9, 2024, with a value of $319,361.
Latest Holdings of Jason Drew Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2024-09-09 | 25,226 | 12.66 | 319,361 |
Holding Weightings of Jason Drew Smith
Jason Drew Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason Drew Smith has made a total of 9 transactions in UroGen Pharma Ltd (URGN) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in UroGen Pharma Ltd is the sale of 1,521 shares on September 9, 2024, which brought Jason Drew Smith around $19,895.
Insider Trading History of Jason Drew Smith
- 1
Jason Drew Smith Trading Performance
GuruFocus tracks the stock performance after each of Jason Drew Smith's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason Drew Smith is -7.27%. GuruFocus also compares Jason Drew Smith's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason Drew Smith within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason Drew Smith's insider trading performs compared to the benchmark.
Performance of Jason Drew Smith
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.14 | | | | | |
| Relative Return to S&P 500(%) | 3.73 | | | | | |
Jason Drew Smith Ownership Network
Jason Drew Smith Owned Company Details
What does UroGen Pharma Ltd do?
Who are the key executives at UroGen Pharma Ltd?
Jason Drew Smith is the General Counsel of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include Chief Medical Officer Mark Schoenberg , Chief Financial Officer Dong Kim , and Chief Financial Officer Molly Henderson .
UroGen Pharma Ltd (URGN) Insider Trades Summary
Over the past 18 months, Jason Drew Smith made 4 insider transaction in UroGen Pharma Ltd (URGN) with a net sale of 15,307. Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 25,590 shares made by Mark Schoenberg ,
In summary, during the past 3 months, insiders sold 2,380 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 2,380 shares. During the past 18 months, 40,897 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,897 shares.
UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
UroGen Pharma Ltd Insider Transactions
Jason Drew Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Jason Drew Smith. You might contact Jason Drew Smith via mailing address: C/o Urogen Pharma Ltd., 400 Alexander Park Drive, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
